Wednesday, July 23, 2025

Creating liberating content

Let’s start with the OG of Indian expressways. Opened in

Trading activity is expected to be driven by company-specific developments

Related News

What should have been a joyful birthday turned into a terrifying health scare for a 16-year-old girl in China’s Hunan province. The teen, known only as Mei, wanted to look

Let’s start with the OG of Indian expressways. Opened in 2002, this six-lane expressway was India’s first concrete, access-controlled highway. Initially, it was opened without a speed limit, which was

Gold price prediction: Gold prices may see further consolidative moves trading in a tight range in near term. (AI image) Gold price prediction today: Gold prices will continue to be

Trading activity is expected to be driven by company-specific developments as more firms report their financial results. (AI image) Stock market today: Nifty50 and BSE Sensex, the Indian equity benchmark

Top stocks to buy today (AI image) Stock market recommendations: According to Mehul Kothari, DVP – Technical Research, Anand Rathi Shares and Stock Brokers, RHI Magnesita India, Exide Industries, and

MUMBAI: An SBI report has cautioned that aggressive tax enforcement targeting small businesses could undermine the gains of formalisation under the GST. In a research note, the bank cautioned that

Trending News

Gold price prediction: Gold prices may see further consolidative moves trading in a tight range in near term. (AI image) Gold price prediction today: Gold prices will continue to be

Trading activity is expected to be driven by company-specific developments as more firms report their financial results. (AI image) Stock market today: Nifty50 and BSE Sensex, the Indian equity benchmark

Top stocks to buy today (AI image) Stock market recommendations: According to Mehul Kothari, DVP – Technical Research, Anand Rathi Shares and Stock Brokers, RHI Magnesita India, Exide Industries, and

MUMBAI: Paytm swung to profit in the June quarter after two straight quarters of losses, posting net profits of Rs 123 crore on a consolidated basis as attempts to check

US President Donald Trump announced on Tuesday that America has finalised a trade agreement with Japan, which includes a 15 percent American tariff on Japanese imports and a $550 billion

US president Donald Trump on Tuesday announced that the Philippines will pay a 19% tariff under a new trade agreement between the two countries.“It was a beautiful visit, and we

US tariff: ‘No major impact on pharma’

Word Count: 713 | Estimated Reading Time: 4 minutes


US tariff: 'No major impact on pharma'
The domestic pharma industry in India may not face significant impact from potential US tariffs on pharmaceutical exports. Indian generics, which dominate exports and are in continuous demand, could absorb additional costs. Key industry players are awaiting further details on the tariffs while engaging in bilateral talks.

NEW DELHI: The domestic pharma industry may not be significantly impacted by potential US retaliatory tariffs as most exports to the US include low-cost, price-inelastic generics that remain in constant demand.
Indian pharma exports to the US, valued nearly $10 billion, mainly include oral formulations, and any additional cost burden would likely be shared between consumers, healthcare providers, and domestic companies, analysts told TOI.
India is a major supplier to the US, providing over 45% of its generic medicines, driven by an ageing population and demand for cost-effective healthcare. Given this, no country would likely disrupt such a critical supply chain.
Pharma stocks were under pressure on Feb 19, following comments from US President Donald Trump, who signalled that the US may impose tariffs of around 25% on pharmaceutical, automobiles and semiconductor imports. The industry is in a wait-and-watch mode, awaiting clarity on the details of potential tariffs, and is hopeful that a resolution may be reached through bilateral talks.
“Indian pharmaceutical industry plays a vital role in ensuring access to affordable, quality-assured medicines in the US, supplying nearly 47% of the generic medicines for American patients and contributing significantly to the country’s healthcare savings. The proposal regarding reciprocal tariffs is currently under talks and is being examined. This matter will be discussed through bilateral engagements,” Sudarshan Jain, secretary general, Indian Pharma Alliance said.
An imposition of a potential tariff would make a small difference in absolute terms for certain players, analysts feel. In some cases, widely-sold paracetamol, azithromycin, cephalosporins cost as low as 2 cents a tablet.
“The effect will be more on innovators than generics as generics are very low in value. Some of these will be passed on and some will be absorbed by the seller. We will have to wait and see the financial impact,” Sujay Shetty, global health industries advisory leader, PwC India said.
“We don’t see much of a significant impact on Indian pharma (as of now). India is a strategic partner, which meets about 45-50% of the US requirements of generic medicines,” Deepak Jotwani of Icra said.





Source link

Most Popular Articles